A striking new survey reveals a massive gap in women’s health education: 66% of American women between 38 and 50 report feeling more prepared for puberty than perimenopause. That’s the finding behind Flo Health’s latest push to transform how women navigate one of life’s most significant biological transitions.
What Happened
Flo Health commissioned Wakefield Research to conduct a nationally representative survey examining women’s preparedness for major life transitions. The results underscore a troubling reality: despite decades of public health campaigns, perimenopause remains shrouded in mystery for most American women. Unlike puberty, which is addressed in schools and homes, perimenopause catches many women off guard, leaving them to manage symptoms and life changes without adequate preparation or support.
The timing is significant. With an estimated 1.3 million American women entering perimenopause each year, the lack of accessible, reliable information creates a substantial market opportunity for health tech companies willing to tackle the issue head-on.
Key Points
Flo Health, best known for its menstrual and fertility tracking app, is leveraging its existing user base and AI capabilities to address the perimenopause education crisis. The company has expanded its platform to include comprehensive perimenopause tracking, symptom management tools, and personalized insights powered by machine learning algorithms.
The survey data reveals that women want better information sources. Many report relying on social media, friends, or outdated resources rather than trusted medical guidance. Flo Health’s approach combines community-driven knowledge with clinical expertise, creating a hybrid model that resonates with its predominantly millennial and Gen X female audience.
The company’s expansion into perimenopause represents a natural evolution beyond fertility tracking, tapping into the growing femtech sector that has attracted billions in venture capital investment over the past five years.
What This Means
This initiative signals a broader shift in healthcare technology toward addressing historically overlooked women’s health issues. By democratizing perimenopause information, Flo Health positions itself as an essential resource during a critical life stage, potentially increasing user retention and expanding its addressable market.
For the tech industry, it demonstrates the commercial viability of solving real healthcare gaps while serving underserved populations. For women, it means access to evidence-based information at their fingertips—filling a void that traditional healthcare has largely ignored.
As perimenopause affects quality of life for millions, companies like Flo Health prove that technology, combined with compassionate design, can genuinely improve health outcomes when traditional systems fall short.
